JP2013541513A5 - - Google Patents

Download PDF

Info

Publication number
JP2013541513A5
JP2013541513A5 JP2013526466A JP2013526466A JP2013541513A5 JP 2013541513 A5 JP2013541513 A5 JP 2013541513A5 JP 2013526466 A JP2013526466 A JP 2013526466A JP 2013526466 A JP2013526466 A JP 2013526466A JP 2013541513 A5 JP2013541513 A5 JP 2013541513A5
Authority
JP
Japan
Prior art keywords
alkyl
group
heterocycle
carbocycle
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013526466A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013541513A (ja
JP6048406B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/065080 external-priority patent/WO2012028676A1/en
Publication of JP2013541513A publication Critical patent/JP2013541513A/ja
Publication of JP2013541513A5 publication Critical patent/JP2013541513A5/ja
Application granted granted Critical
Publication of JP6048406B2 publication Critical patent/JP6048406B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013526466A 2010-09-02 2011-09-01 新規化合物、医薬組成物及びこれらの使用 Expired - Fee Related JP6048406B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10175100.6 2010-09-02
EP10175100 2010-09-02
PCT/EP2011/065080 WO2012028676A1 (en) 2010-09-02 2011-09-01 New compounds, pharmaceutical compositions and uses thereof

Publications (3)

Publication Number Publication Date
JP2013541513A JP2013541513A (ja) 2013-11-14
JP2013541513A5 true JP2013541513A5 (enExample) 2014-10-23
JP6048406B2 JP6048406B2 (ja) 2016-12-21

Family

ID=44583007

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013526466A Expired - Fee Related JP6048406B2 (ja) 2010-09-02 2011-09-01 新規化合物、医薬組成物及びこれらの使用

Country Status (4)

Country Link
US (1) US8835472B2 (enExample)
EP (1) EP2611771B1 (enExample)
JP (1) JP6048406B2 (enExample)
WO (1) WO2012028676A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2835332C (en) * 2011-05-10 2019-03-26 Sandoz Ag Polymorph of linagliptin benzoate
US8530460B2 (en) 2011-12-19 2013-09-10 Boehringer Ingelheim International Gmbh Azetidine derivatives
FR3000491B1 (fr) 2012-09-27 2015-08-28 Univ Lille Ii Droit & Sante Composes utilisables dans le traitement des infections mycobacteriennes
US9371282B2 (en) 2013-05-17 2016-06-21 Centrexion Therapeutics Corporation Somatostatin receptor subtype 4 (SSTR4) agonists
WO2015036892A1 (en) 2013-09-12 2015-03-19 Pfizer Inc. Use of acetyl-coa carboxylase inhibitors for treating acne vulgaris
US10029986B2 (en) 2014-02-18 2018-07-24 Nissan Chemical Industries, Ltd. Alkynyl pyridine-substituted amide compound and pesticide
AU2016275764B8 (en) * 2015-06-11 2021-03-04 Basilea Pharmaceutica International AG Efflux-pump inhibitors and therapeutic uses thereof
WO2017117708A1 (en) * 2016-01-05 2017-07-13 Hua Medicine (Shanghai) Ltd. Pyrazole derivatives
WO2018003924A1 (ja) * 2016-06-29 2018-01-04 日産化学工業株式会社 アルキニルピリジン置換アミド化合物及び有害生物防除剤
AR119731A1 (es) * 2019-05-17 2022-01-05 Novartis Ag Inhibidores del inflamasoma nlrp3
CN112979612B (zh) * 2021-02-21 2022-09-09 苏州大学 一种室温制备2-碘代杂环芳醚的方法
WO2022174468A1 (zh) * 2021-02-22 2022-08-25 苏州大学 一种室温制备2-碘代杂环芳醚的方法
CN115605457B (zh) * 2021-04-26 2025-03-18 三菱瓦斯化学株式会社 化合物及其制造方法
AR127055A1 (es) 2021-09-14 2023-12-13 Lilly Co Eli Sales agonistas de sstr4
US20250332138A1 (en) * 2022-01-27 2025-10-30 Vivozon, Inc. Pharmaceutical composition for preventing or treating mental disorder
UY40374A (es) 2022-08-03 2024-02-15 Novartis Ag Inhibidores de inflamasoma nlrp3

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2176854A1 (en) * 1995-06-07 1996-12-08 Daniel J. Keavy N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
US6284796B1 (en) * 1998-08-06 2001-09-04 Abbott Laboratories Ukokinase inhibitors
US20050171358A1 (en) * 2002-03-07 2005-08-04 Noriko Shimozono Substituted isoxazole alkylamine derivative and agri-and horticultural fungicide
ES2332184T3 (es) 2004-03-22 2010-01-28 ELI LILLY & COMPANY Derivados de piridilo y su uso como antagonistas del receptor mglu5.
WO2006016548A1 (ja) * 2004-08-09 2006-02-16 Eisai R & D Management Co., Ltd. ヘテロ環化合物を含有する新規な抗マラリア剤
TWI366438B (en) * 2004-08-12 2012-06-21 Ishihara Sangyo Kaisha Fungicidal composition containing acid amide derivative
SI1794163T1 (sl) 2004-09-22 2010-04-30 Pfizer Postopek priprave inhibitorjev poli(ADP-riboza) polimeraz
WO2006094800A2 (en) * 2005-03-04 2006-09-14 Synthon B.V. Cascade reaction process
JP2008534565A (ja) * 2005-03-31 2008-08-28 アストラゼネカ アクチボラグ Ｔｉｅ２阻害活性のあるアミノピリミジン誘導体
KR20090016512A (ko) * 2006-06-08 2009-02-13 신젠타 파티서페이션즈 아게 Ｎ-(ｌ-알킬-2-페닐에틸)-카복스아미드 유도체 및 살진균제로서의 이의 용도
JP2010502617A (ja) * 2006-08-31 2010-01-28 シェーリング コーポレイション 抗菌物質として有用なヒダントイン誘導体
TW201716375A (zh) * 2007-06-12 2017-05-16 Achaogen Inc 抗菌劑
BRPI0812994A2 (pt) * 2007-06-15 2014-12-23 Syngenta Participations Ag Microbiocidas
WO2009024342A2 (en) * 2007-08-23 2009-02-26 Syngenta Participations Ag Novel microbiocides
MX2010004718A (es) * 2007-11-01 2010-07-28 Acucela Inc Compuestos derivados de amina para tratar enfermedades y trastornos oftalmicos.
EA020885B1 (ru) 2008-01-22 2015-02-27 Мерк Патент Гмбх Ингибиторы протеинкиназы и их применение
GB0807140D0 (en) * 2008-04-18 2008-05-21 Syngenta Participations Ag Novel microbiocides
US8501804B2 (en) 2008-10-27 2013-08-06 Takeda Pharmaceutical Company Limited Bicyclic compound
JP2012162460A (ja) * 2009-05-27 2012-08-30 Nippon Soda Co Ltd 含窒素ヘテロアリール誘導体および農園芸用殺菌剤
US8883778B2 (en) 2009-07-01 2014-11-11 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
US8389536B2 (en) 2009-10-27 2013-03-05 Hoffmann-La Roche Inc. Positive allosteric modulators (PAM)

Similar Documents

Publication Publication Date Title
JP2013541513A5 (enExample)
CN107108637B (zh) 三唑并嘧啶化合物及其用途
AU2018358160B2 (en) Modulators of the integrated stress pathway
RU2013126094A (ru) Замещённые пиразолопиримидины как активаторы глюкоцереброзидазы
US20240307382A1 (en) Modulators of the integrated stress pathway
CN109963854A (zh) 杂芳基并[4,3-c]嘧啶-5-胺类衍生物、其制备方法及其在医药上的应用
US20240018133A1 (en) Modulators of the integrated stress pathway
JP2011500545A5 (enExample)
RU2015116816A (ru) Производное имидазола
RU2350609C2 (ru) Производные бензофурана и бензотиофена, применяемые при лечении гиперпролиферативных заболеваний
TW200835485A (en) Novel aminopyrimidine derivatives as PLK1 inhibitors
JP2015526519A5 (enExample)
NZ603724A (en) Piperidine derivatives and their use for the treatment of metabolic disorders
RU2009123525A (ru) ПРОИЗВОДНЫЕ 5-СУЛЬФАНИЛМЕТИЛ[1,2,4}ТРИАЗОЛ[1,5-а]ПИРИМИДИН-7-ОЛА В КАЧЕСТВЕ АНТАГОНИСТОВ CXCR2
JP2014516070A5 (enExample)
JP2016508135A5 (enExample)
JP2013523814A5 (enExample)
RU2012108423A (ru) Ацилгуанидиновые производные с азотсодержащим циклом
JP2013540714A5 (enExample)
JP2015500856A5 (enExample)
RU2014144951A (ru) Новое 1-замещенное производное индазола
RU2018143284A (ru) Некоторые ингибиторы протеинкиназы
EP3479843A1 (en) Use of nox inhibitors for treatment of cancer
JP2015500267A5 (enExample)
CA2553704A1 (en) Substituted benzimidazoles and their use for inducing apoptosis